Nr566 Final / Expert Strategies, Review of
Complete Quizzes, And Practice Questions for
Guaranteed Success, 2025/2026.
Terms in this set (165)
A postmenopausal patient ANSWER: D
who has had a hysterectomy Estrogens for intravaginal administration are used for local
and who has a family history effects, primarily to treat vulval and vaginal atrophy. Because
these preparations bypass the liver, the total dose is reduced
of coronary heart disease
and there is a lower risk of systemic effects. Depo Provera is
reports experiencing vaginal a progesterone and is not indicated. Transdermal estrogen is
dryness and pain with used to treat hot flushes. Low-dose estrogens still have
intercourse but tells the systemic effects.
nurse that she does not want
to take hormones because
she is afraid of adverse
effects. The nurse will
suggest that the woman ask
her provider about:
1. Depo Provera.
2. Estraderm.
3. low-dose estrogens.
4. Premarin vaginal.
,A 50-year-old ANSWER: D
postmenopausal patient Transdermal preparations of estrogen have fewer adverse
who has had a hysterectomy effects, use lower doses of estrogen, and have less
has moderate to severe fluctuation of estrogen levels than do oral preparations.
vasomotor symptoms and is Progesterone is contraindicated in women who have
discussing estrogen therapy undergone hysterectomy.
(ET) with the nurse. The Intravaginal preparations are most useful for treating local
patient is concerned about estrogen deficiency such as vaginal and vulvar atrophy. Side
effects of ET are the same at the patient's age as for other
adverse effects of ET. The
women using
nurse will tell her that: 1. an
estrogen-
progesterone product will
reduce side effects. 2. an
intravaginal preparation may
be best for her.
3. side effects of ET are
uncommon among women
her age. 4. transdermal
preparations have fewer
side effects.
,A patient who will begin ANSWER: A
combination In patients who still have a uterus, progestin is necessary to
estrogen/progestin therapy reduce the risk of endometrial carcinoma. Progestins do not
have effects on bone density and do not decrease risk of MI
(EPT) for menopause asks
or DVT.
the nurse why she cannot
take an estrogen-only
preparation. The patient has
not had a hysterectomy, has
a slightly increased risk of
cardiovascular disease, and
has mild osteopenia. The
nurse will tell her that the
progestin is necessary to:
1. decrease her risk of
endometrial cancer. 2.
increase bone
resorption to prevent
fractures.
3. lower her risk of
myocardial infarction (MI). 4.
prevent deep vein
thrombosis (DVT).
, A nurse provides teaching to ANSWER: C
a patient who has had a For patients who have undergone hysterectomy, progestin
hysterectomy and is about to is unnecessary; estrogen-only preparations still carry
increased risk of breast cancer and should be taken in the
begin hormone therapy to
lowest effective dose for the shortest time possible. Even
manage menopausal though uterine cancer is no longer a possibility, breast
symptoms. Which statement cancer is still a risk. Studies have shown no protection
by the patient indicates against coronary heart disease but increased risk of stroke
and breast cancer with estrogens.
understanding of the
teaching?
1. "Because I am not at
riskfor uterine cancer, I can
take hormones
indefinitely."
2. "I can take estrogen
toreduce my risk of
cardiovascular disease." 3. "I
should take the lowest
effective dose for the
shortest time needed."
4. "I will need a
progestin/estrogen
combination since I have had
a hysterectomy."
Complete Quizzes, And Practice Questions for
Guaranteed Success, 2025/2026.
Terms in this set (165)
A postmenopausal patient ANSWER: D
who has had a hysterectomy Estrogens for intravaginal administration are used for local
and who has a family history effects, primarily to treat vulval and vaginal atrophy. Because
these preparations bypass the liver, the total dose is reduced
of coronary heart disease
and there is a lower risk of systemic effects. Depo Provera is
reports experiencing vaginal a progesterone and is not indicated. Transdermal estrogen is
dryness and pain with used to treat hot flushes. Low-dose estrogens still have
intercourse but tells the systemic effects.
nurse that she does not want
to take hormones because
she is afraid of adverse
effects. The nurse will
suggest that the woman ask
her provider about:
1. Depo Provera.
2. Estraderm.
3. low-dose estrogens.
4. Premarin vaginal.
,A 50-year-old ANSWER: D
postmenopausal patient Transdermal preparations of estrogen have fewer adverse
who has had a hysterectomy effects, use lower doses of estrogen, and have less
has moderate to severe fluctuation of estrogen levels than do oral preparations.
vasomotor symptoms and is Progesterone is contraindicated in women who have
discussing estrogen therapy undergone hysterectomy.
(ET) with the nurse. The Intravaginal preparations are most useful for treating local
patient is concerned about estrogen deficiency such as vaginal and vulvar atrophy. Side
effects of ET are the same at the patient's age as for other
adverse effects of ET. The
women using
nurse will tell her that: 1. an
estrogen-
progesterone product will
reduce side effects. 2. an
intravaginal preparation may
be best for her.
3. side effects of ET are
uncommon among women
her age. 4. transdermal
preparations have fewer
side effects.
,A patient who will begin ANSWER: A
combination In patients who still have a uterus, progestin is necessary to
estrogen/progestin therapy reduce the risk of endometrial carcinoma. Progestins do not
have effects on bone density and do not decrease risk of MI
(EPT) for menopause asks
or DVT.
the nurse why she cannot
take an estrogen-only
preparation. The patient has
not had a hysterectomy, has
a slightly increased risk of
cardiovascular disease, and
has mild osteopenia. The
nurse will tell her that the
progestin is necessary to:
1. decrease her risk of
endometrial cancer. 2.
increase bone
resorption to prevent
fractures.
3. lower her risk of
myocardial infarction (MI). 4.
prevent deep vein
thrombosis (DVT).
, A nurse provides teaching to ANSWER: C
a patient who has had a For patients who have undergone hysterectomy, progestin
hysterectomy and is about to is unnecessary; estrogen-only preparations still carry
increased risk of breast cancer and should be taken in the
begin hormone therapy to
lowest effective dose for the shortest time possible. Even
manage menopausal though uterine cancer is no longer a possibility, breast
symptoms. Which statement cancer is still a risk. Studies have shown no protection
by the patient indicates against coronary heart disease but increased risk of stroke
and breast cancer with estrogens.
understanding of the
teaching?
1. "Because I am not at
riskfor uterine cancer, I can
take hormones
indefinitely."
2. "I can take estrogen
toreduce my risk of
cardiovascular disease." 3. "I
should take the lowest
effective dose for the
shortest time needed."
4. "I will need a
progestin/estrogen
combination since I have had
a hysterectomy."
